NCBiotech News

GLAS, a Winston-Salem company that provides human biospecimens and consulting services to medical researchers, has been acquired by Precision for Medicine of Bethesda, Md.

Chapel Hill’s Path BioAnalytics, a precision-medicine company focused on new treatments for respiratory disease, has licensed rights to a cystic fibrosis drug candidate from a Chinese biopharmaceutical company.

Among the fastest-growing young companies in America, 135 of them can be found right here in North Carolina, according to the latest Inc. 5000 list. And Raleigh life science consulting firm Eva Garland Consulting is on the list again.

The growing number of agricultural biotechnology companies and jobs in North Carolina has motivated Alamance Community College in Graham to offer the state’s first and only associate’s degree program in the field.

Pfizer announced today that it will invest an additional $500 million and add 300 more jobs to increase its newly completed gene therapy manufacturing capabilities at its 230-acre campus in Sanford, North Carolina.

North Carolina is a global leader in gene therapy thanks to its renowned workforce development programs and the scientific output of its research universities.

A multi-year collaboration to help improve outcomes for patients with head and neck cancer has advanced to a second phase for Research Triangle Park-based GeneCentric Therapeutics, Inc.  

Finally, a new, more-effective drug taken for shorter duration, when used in combination with two others, is here to fight the worst types of tuberculosis. And a scientist at RTI International helped it happen.

Durham's Heat Biologics has received an FDA go-ahead to start a Phase 1 clinical trial to evaluate combining two of its immune-stimulating cell lines in patients with solid tumors resistant to standard treatment.

The North Carolina Biotechnology Center will open the doors to its Conference Center on August 28 so potential clients can get to know its array of hosting amenities.

Emboldened by a recent cash infusion of $225 million from investors, AskBio has acquired Scottish company Synpromics to help it develop therapeutics for a wider array of genetic disorders than the rare diseases it has targeted to date. 

A group representing North Carolina’s BioPharma Crescent has a few more ideas now about such things as cell and gene therapies and digital solutions for pharmaceutical packaging. And a lot of people from around the world are aware of North Carolina’s BioPharma Crescent.

Four of North Carolina's key agricultural partners are coming together in a collaborative effort to highlight the contributions women have made to the agriculture industry in North Carolina.

Leading women across the state are changing the future beyond the farm. Innovations, resources, opportunities and experiences will be shared on tour and social platforms to showcase the impact women have on North Carolina’s agriculture industry.

The North Carolina Biotechnology Center awarded 22 grants and loans totaling $2,050,778 to universities, bioscience companies and other organizations in the fourth quarter of its fiscal year.

Durham-based Chimerix,has committed $30 million and10 million shares of its common stock to buy exclusive worldwide rights to a leukemia drug under development by Cantex Pharmaceuticals Inc.